Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Atif Zaman is active.

Publication


Featured researches published by Atif Zaman.


NEJM Journal Watch | 2006

Mother-to-Child Transmission of HCV Infection

Atif Zaman

Risk estimates for mother-to-child transmission of hepatitis C virus (HCV) vary from 3% to 10%, but risk factors for transmission are poorly


NEJM Journal Watch | 2018

Thrombocytopenia Is Not a Predictor of Unprovoked Bleeding in Cirrhosis

Atif Zaman

The relationship between platelet count and unprovoked major or minor bleeding risk in patients with cirrhosis is unclear.In a prospective,


NEJM Journal Watch | 2018

Long-Term Renal Effects of Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic HBV-Infected Patients

Atif Zaman

The majority of patients who receive oral antiviral therapy for chronic hepatitis B virus (HBV) infection will require long-term viral suppression,


NEJM Journal Watch | 2018

Prevalence of Liver Fibrosis in a General Population

Atif Zaman

The degree of fibrosis is the key prognostic indicator in people with liver disease. Previous estimates of the prevalence of liver fibrosis among the


NEJM Journal Watch | 2018

Ribavirin-Free, 12-Week DAA Regimens for HCV Recurrence After Liver Transplantation

Atif Zaman

The current recommended therapy for recurrent hepatitis C virus (HCV) infection after liver transplantation is a combination of direct-acting antiviral


NEJM Journal Watch | 2018

Effect of Ribavirin in Anti–HCV Genotype 3 Therapy in Patients with Cirrhosis

Atif Zaman

Studies demonstrate lower efficacy of direct-acting antiviral agents (DAAs) in hepatitis C virus (HCV) genotype 3–infected patients when cirrhosis is


NEJM Journal Watch | 2018

New Guideline for Management of Alcoholic Liver Disease

Atif Zaman

Sponsoring Organization: American College of Gastroenterology (ACG)Target Audience: Hepatologists, gastroenterologists, primary care


NEJM Journal Watch | 2018

Long-Term Outcomes of HCV-Related Cryoglobulinemia Vasculitis Treated with Direct-Acting Antiviral Agents

Atif Zaman

Recent studies demonstrate that direct-acting antiviral agents (DAAs) are safe and effective at eradicating hepatitis C virus (HCV)–related


NEJM Journal Watch | 2018

Norfloxacin as Primary Prophylaxis for Spontaneous Bacterial Peritonitis

Atif Zaman

Norfloxacin therapy has been investigated for its potential to prevent spontaneous bacterial peritonitis (SBP) and improve survival in patients with


NEJM Journal Watch | 2018

New Therapeutic Options for Variceal Bleeding

Atif Zaman

In a review article, researchers summarize recent advancements in the diagnosis, prognosis, and treatment of variceal hemorrhage in patients with

Collaboration


Dive into the Atif Zaman's collaboration.

Researchain Logo
Decentralizing Knowledge